COL6A3 and coronary artery disorder: Lower plasma levels of COL6A3-derived endotrophin (A-allele of rs11677932; β = −0.07, P = 1.5 × 10−14) were associated with increased heel-bone mineral density (β = 0.02, P = 2.9 × 10−19) and increased lung function (FEV1/FVC) (β = 0.02, P = 5.2 × 10−13), in addition to a reduced risk of CAD (β = −0.03, P = 2.7 × 10−12) (Supplementary Table 20).